Thus, our results propose that functional P2Y2R activation in highly metastatic breast cancer cells MDA-MB-231 mediate the signaling pathways that are involved in metastasis, and further study is needed to examine the signaling differences between MDA-MB-231 and MCF-7. Here, P2RY2 is linked to breast carcinoma.